PPT-Urine Based Molecular Assay for Early Detection of Prostate Cancer in Context of Race
Author : kade | Published Date : 2024-09-06
Indu Kohaar PhD Assistant Professor USU Walter Reed Surgery Henry M Jackson Foundation DISCLAIMER The contents of this publication are the sole responsibility of
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Urine Based Molecular Assay for Early De..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Urine Based Molecular Assay for Early Detection of Prostate Cancer in Context of Race: Transcript
Indu Kohaar PhD Assistant Professor USU Walter Reed Surgery Henry M Jackson Foundation DISCLAIMER The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views opinions or policies of Uniformed Services University of the Health Sciences USUHS The Henry M Jackson Foundation for the Advancement of Military Medicine Inc the Department of Defense DoD the Departments of the Army Navy or Air Force Mention of trade names commercial products or organizations does not imply endorsement by the US Government. Essex Biomedical . Sciences Institute (EBSI) . Elena Klenova, University of Essex. the search for a magic molecule. Most Common Types of Cancers in Men. info.cancerresearchuk.org/.../males/index.htm. Analysis. Charles . J Ryan, MD. Professor of Clinical . Medicine and Urology. Helen Diller Family Comprehensive Cancer Center. University of California, San Francisco. Biomarker Analysis in Prostate . The second most common cancer diagnosed in men. The incidence increase with age very rare before age of 40, more in western countries particularly Scandinavian countries (low light exposure), and black men are at greatest risk. When to Image Based on . Choosing . Wisely. ®. . and ACR Appropriateness . Criteria. ®. What Is R-SCAN?. 2. C. ollaborative activity . for referring clinicians and radiologists to improve patient . Andrew J Armstrong MD . ScM. FACP. National Alliance of State Prostate Cancer Coalitions Webinar Series . November 2020. Professor of Medicine and Surgery, Pharmacology and Cancer Biology. Director of Research, Duke Cancer Institute . Stacy Loeb, MD MSc PhD (Hon). @LoebStacy. Professor of Urology and Population Health,. New York University and Manhattan Veterans Affairs. www.stacyloeb.com. Sleep Health. Lisa . Fotios. , . Pexels. How is your sleep? . cancer. Khanmi. . Kasomva. ,. Ph.D. . Research . Scholar,. Biotechnology & Molecular Biology Unit, . ERI, . Loyola . College. Chennai, . Inida. .. . . . What we will be discussing about. The prostate is a gland the size of a walnut it sits at the neck of the bladder. Only men have a prostate gland!. Prostate cancer is the commonest type of male cancer . By far the biggest risk factor is age . 1 Brachytherapy Treatment for Prostate Cancer One of the side effects is erectile dysfunction. It may not be suitable for men who already have urinary problems. Urinary problems such as incontinenc 1 Summary cancer type worldwide and is one of the most challenging and expensive cancers to diagnose and treat. Its diagnosis relies on cystoscopy, an invasive and expensive procedure that might n Dr Marie-Pier St-Laurent, MD, FRCSC. Urologic-Oncology fellow, UBC. Research scientist, Vancouver Prostate Centre. Honorarium: Bayer, PCSC. As a urologist, I am biased towards prostate cancer screening.. In association with. What is Prostate Cancer?. Prostate cancer affects 1 in 8 males. And 1 in 4 African – Caribbean men . The Prostate . What is Prostate Cancer?. What are the risk factors?. Age. Session Objectives. Updates of the Status of Research Effort. Evaluation of Biomarker Development Status. Imaging and Urine Testing to Enhance Prostate Cancer Detection. Martin . Sanda. , M.D., Emory University. CVC. ngs. ) of biopsy specimen. Molecular Cancer Classifier can Determine the Cancer Type, but Not Genetic Alterations in Cancer Cells. Comprehensive Profiling (NGS) Can Determine Genetic Alterations in Cancer Cells, but Can Not Determine the Cancer...
Download Document
Here is the link to download the presentation.
"Urine Based Molecular Assay for Early Detection of Prostate Cancer in Context of Race"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents